rs4726460

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001061.7(TBXAS1):​c.334-11517G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.399 in 151,926 control chromosomes in the GnomAD database, including 13,957 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 13957 hom., cov: 31)

Consequence

TBXAS1
NM_001061.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.649

Publications

3 publications found
Variant links:
Genes affected
TBXAS1 (HGNC:11609): (thromboxane A synthase 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. The enzyme plays a role in several pathophysiological processes including hemostasis, cardiovascular disease, and stroke. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
TBXAS1 Gene-Disease associations (from GenCC):
  • ghosal hematodiaphyseal dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.498 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001061.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBXAS1
NM_001061.7
MANE Select
c.334-11517G>A
intron
N/ANP_001052.3P24557-1
TBXAS1
NM_001166253.4
c.334-11517G>A
intron
N/ANP_001159725.2P24557-3
TBXAS1
NM_001130966.5
c.334-11517G>A
intron
N/ANP_001124438.2P24557-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBXAS1
ENST00000448866.7
TSL:1 MANE Select
c.334-11517G>A
intron
N/AENSP00000402536.3P24557-1
TBXAS1
ENST00000336425.10
TSL:1
c.334-11517G>A
intron
N/AENSP00000338087.7P24557-1
TBXAS1
ENST00000425687.5
TSL:1
c.133-11517G>A
intron
N/AENSP00000388736.1P24557-2

Frequencies

GnomAD3 genomes
AF:
0.400
AC:
60654
AN:
151806
Hom.:
13951
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.546
Gnomad AMR
AF:
0.458
Gnomad ASJ
AF:
0.441
Gnomad EAS
AF:
0.435
Gnomad SAS
AF:
0.305
Gnomad FIN
AF:
0.587
Gnomad MID
AF:
0.326
Gnomad NFE
AF:
0.503
Gnomad OTH
AF:
0.398
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.399
AC:
60671
AN:
151926
Hom.:
13957
Cov.:
31
AF XY:
0.404
AC XY:
30002
AN XY:
74250
show subpopulations
African (AFR)
AF:
0.161
AC:
6650
AN:
41424
American (AMR)
AF:
0.459
AC:
7005
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.441
AC:
1530
AN:
3472
East Asian (EAS)
AF:
0.436
AC:
2248
AN:
5160
South Asian (SAS)
AF:
0.305
AC:
1465
AN:
4808
European-Finnish (FIN)
AF:
0.587
AC:
6188
AN:
10540
Middle Eastern (MID)
AF:
0.330
AC:
97
AN:
294
European-Non Finnish (NFE)
AF:
0.503
AC:
34156
AN:
67940
Other (OTH)
AF:
0.396
AC:
836
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1662
3324
4985
6647
8309
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
564
1128
1692
2256
2820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.434
Hom.:
2041
Bravo
AF:
0.381
Asia WGS
AF:
0.354
AC:
1229
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.6
DANN
Benign
0.48
PhyloP100
-0.65
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4726460; hg19: chr7-139624473; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.